کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5870330 1140360 2015 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Advances in Hepatitis C Treatment: At the Crossroads
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله
Advances in Hepatitis C Treatment: At the Crossroads
چکیده انگلیسی
Chronic hepatitis C virus (HCV) infection is a serious public health problem. Globally, over 170 million persons are infected and suffer from HCV infection, cirrhosis, and hepatocellular carcinoma. HCV infection is among the leading causes of death in the United States. Recently, there have been newer, direct-acting antiviral agents approved by the US Food and Drug Administration for treatment of HCV for genotypes 1-4. The aim of this study is to evaluate the clinical efficacy, pharmacologic properties, and safety profiles from clinical trials and the costs associated with the new antiviral regimens, including sofosbuvir, simeprevir, and ledipasvir/sofosbuvir.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The Journal for Nurse Practitioners - Volume 11, Issue 7, July–August 2015, Pages 669-679
نویسندگان
, , , , ,